Cargando…

Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

BACKGROUND: Currently, there are no satisfactory biomarkers available to screen for diffuse large B cell lymphoma (DLBCL) or to identify patients who do not benefit from standard anti-cancer therapies. In this study, we used serum proteomic mass spectra to identify potential serum biomarkers and bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xing, Wang, Bo, Zhang, Xiao-shi, Li, Zhi-ming, Guan, Zhong-zhen, Jiang, Wen-qi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242801/ https://www.ncbi.nlm.nih.gov/pubmed/18163913 http://dx.doi.org/10.1186/1471-2407-7-235

Ejemplares similares

SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma
por: Huang, Yuan-Jiao, et al.
Publicado: (2009)

The Application of SELDI-TOF-MS in Clinical Diagnosis of Cancers
por: Liu, Chibo
Publicado: (2011)

Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer
por: Wang, Qi, et al.
Publicado: (2009)

Research progress in SELDI-TOF MS and its clinical applications
por: CHO, William Chi-Shing
Publicado: (2006)

Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling
por: Gast, Marie-Christine W, et al.
Publicado: (2008)

SELDI-TOF-MS Serum Profiling Reveals Predictors of Cardiac MRI Changes in Marathon Runners
por: Wilson, George D., et al.
Publicado: (2012)

SELDI-TOF-MS Proteomic Profiling of Serum, Urine, and Amniotic Fluid in Neural Tube Defects
por: Liu, Zhenjiang, et al.
Publicado: (2014)

Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS
por: De Bock, Muriel, et al.
Publicado: (2010)

Identification of Anoectochilus based on rDNA ITS sequences alignment and SELDI-TOF-MS
por: Gao, Chuan, et al.
Publicado: (2009)

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass
por: Wegdam, Wouter, et al.
Publicado: (2012)

Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay
por: Schweigert, Florian J, et al.
Publicado: (2004)

Pooling serum samples may lead to loss of potential biomarkers in SELDI-ToF MS proteomic profiling
por: Sadiq, S Tariq, et al.
Publicado: (2008)

Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study
por: van Winden, Annemieke WJ, et al.
Publicado: (2009)

Investigation of serum protein profiles in scrapie infected sheep by means of SELDI-TOF-MS and multivariate data analysis
por: Meling, Siv, et al.
Publicado: (2013)

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
por: Van Gorp, Toon, et al.
Publicado: (2012)

SELDI-TOF Serum Profiling for Prognostic and Diagnostic Classification of Breast Cancers
por: Laronga, Christine, et al.
Publicado: (2004)

Application of protein chip combined with SELDI-TOF-MS detection to investigate serum protein expression in patients with silicosis fibrosis
por: Liu, Guitao, et al.
Publicado: (2019)

Reproducible Cancer Biomarker Discovery in SELDI-TOF MS Using Different Pre-Processing Algorithms
por: Zou, Jinfeng, et al.
Publicado: (2011)

Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS
por: Kwapiszewska, Grazyna, et al.
Publicado: (2004)

Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS
por: Campostrini, Natascia, et al.
Publicado: (2010)

Endosulfan-Induced Biomarkers in Japanese Rice Fish (Oryzias latipes) Analyzed by SELDI-TOF-MS
por: Lee, Sung-Eun, et al.
Publicado: (2013)

SELDI-TOF mass spectrometry of High-Density Lipoprotein
por: Levels, Johannes HM, et al.
Publicado: (2007)

Novel approaches to smoothing and comparing SELDI TOF spectra
por: Meleth, Sreelatha, et al.
Publicado: (2007)

Applications of SELDI-MS technology in oncology
por: Whelan, L C, et al.
Publicado: (2008)

Proteins and peptides in parotid saliva of irradiated patients compared to that of healthy controls using SELDI-TOF-MS
por: Laheij, Alexa M. G. A., et al.
Publicado: (2015)

SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard
por: Ward, Douglas G, et al.
Publicado: (2008)

A method for improving SELDI-TOF mass spectrometry data quality
por: Whistler, Toni, et al.
Publicado: (2007)

Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data
por: Tang, Kai-Lin, et al.
Publicado: (2010)

Proteomic analysis of phosphoproteins sensitive to a phosphatidylinositol 3-kinase inhibitor, ZSTK474, by using SELDI-TOF MS
por: Akashi, Tetsuyuki, et al.
Publicado: (2009)

Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS
por: Araki, Yoshio, et al.
Publicado: (2010)

Modifications in Rat Plasma Proteome after Remote Ischemic Preconditioning (RIPC) Stimulus: Identification by a SELDI-TOF-MS Approach
por: Hibert, Pierre, et al.
Publicado: (2014)

Quadratic variance models for adaptively preprocessing SELDI-TOF mass spectrometry data
por: Emanuele, Vincent A, et al.
Publicado: (2010)

Screening of serum protein biomarkers in hemorrhagic cerebral infarction by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology
por: Han, Zongqiang, et al.
Publicado: (2020)

Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
por: Chen, Lei, et al.
Publicado: (2010)

Using Decision Forest to Classify Prostate Cancer Samples on the Basis of SELDI-TOF MS Data: Assessing Chance Correlation and Prediction Confidence
por: Tong, Weida, et al.
Publicado: (2004)

SELDI-TOF analysis of glioblastoma cyst fluid is an approach for assessing cellular protein expression
por: Hoelscher, Martin, et al.
Publicado: (2013)

A Novel Preprocessing Method Using Hilbert Huang Transform for MALDI-TOF and SELDI-TOF Mass Spectrometry Data
por: Wu, Li-Ching, et al.
Publicado: (2010)

Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS)
por: Hong, Huixiao, et al.
Publicado: (2005)

Application of serum SELDI proteomic patterns in diagnosis of lung cancer
por: Yang, Shuan-ying, et al.
Publicado: (2005)

Interest of major serum protein removal for Surface-Enhanced Laser Desorption/Ionization – Time Of Flight (SELDI-TOF) proteomic blood profiling
por: Roche, Stéphane, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_91bvvalmlnl2jj1jp39gj90jq3